184 related articles for article (PubMed ID: 7726516)
1. In vitro and in vivo antistaphylococcal activities of L-695,256, a carbapenem with high affinity for the penicillin-binding protein PBP 2a.
Chambers HF
Antimicrob Agents Chemother; 1995 Feb; 39(2):462-6. PubMed ID: 7726516
[TBL] [Abstract][Full Text] [Related]
2. Binding affinity for penicillin-binding protein 2a correlates with in vivo activity of beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus.
Chambers HF; Sachdeva M; Kennedy S
J Infect Dis; 1990 Sep; 162(3):705-10. PubMed ID: 2387996
[TBL] [Abstract][Full Text] [Related]
3. Excellent activity of FK037, a novel parenteral broad-spectrum cephalosporin, against methicillin-resistant staphylococci.
Mine Y; Watanabe Y; Sakamoto H; Hatano K; Kuno K; Kamimura T; Tawara S; Matsumoto Y; Matsumoto F; Kuwahara S
J Antibiot (Tokyo); 1993 Jan; 46(1):99-119. PubMed ID: 8436564
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial activity of SM-17466, a novel carbapenem antibiotic with potent activity against methicillin-resistant Staphylococcus aureus.
Sumita Y; Nouda H; Kanazawa K; Fukasawa M
Antimicrob Agents Chemother; 1995 Apr; 39(4):910-6. PubMed ID: 7785994
[TBL] [Abstract][Full Text] [Related]
5. PBP 2a mutations producing very-high-level resistance to beta-lactams.
Katayama Y; Zhang HZ; Chambers HF
Antimicrob Agents Chemother; 2004 Feb; 48(2):453-9. PubMed ID: 14742194
[TBL] [Abstract][Full Text] [Related]
6. New mechanism for methicillin resistance in Staphylococcus aureus: clinical isolates that lack the PBP 2a gene and contain normal penicillin-binding proteins with modified penicillin-binding capacity.
Tomasz A; Drugeon HB; de Lencastre HM; Jabes D; McDougall L; Bille J
Antimicrob Agents Chemother; 1989 Nov; 33(11):1869-74. PubMed ID: 2610497
[TBL] [Abstract][Full Text] [Related]
7. Coagulase-negative staphylococci resistant to beta-lactam antibiotics in vivo produce penicillin-binding protein 2a.
Chambers HF
Antimicrob Agents Chemother; 1987 Dec; 31(12):1919-24. PubMed ID: 3439802
[TBL] [Abstract][Full Text] [Related]
8. BAL9141, a novel extended-spectrum cephalosporin active against methicillin-resistant Staphylococcus aureus in treatment of experimental endocarditis.
Entenza JM; Hohl P; Heinze-Krauss I; Glauser MP; Moreillon P
Antimicrob Agents Chemother; 2002 Jan; 46(1):171-7. PubMed ID: 11751129
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo activities of a novel cephalosporin, BMS-247243, against methicillin-resistant and -susceptible staphylococci.
Fung-Tomc JC; Clark J; Minassian B; Pucci M; Tsai YH; Gradelski E; Lamb L; Medina I; Huczko E; Kolek B; Chaniewski S; Ferraro C; Washo T; Bonner DP
Antimicrob Agents Chemother; 2002 Apr; 46(4):971-6. PubMed ID: 11897577
[TBL] [Abstract][Full Text] [Related]
10. Activity of FCE 22101 against methicillin-resistant Staphylococcus aureus and affinity for penicillin binding proteins.
Piddock LJ; Traynor EA; Wise R
J Antimicrob Chemother; 1989 Mar; 23 Suppl C():59-64. PubMed ID: 2732144
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of cefoperazone in combination with sulbactam in experimental Staphylococcus aureus endocarditis in rabbits.
Chambers HF; Fournier MA
J Antimicrob Chemother; 1993 Sep; 32(3):453-8. PubMed ID: 8262867
[TBL] [Abstract][Full Text] [Related]
12. Regulation of penicillin-binding protein activity: description of a methicillin-inducible penicillin-binding protein in Staphylococcus aureus.
Rossi L; Tonin E; Cheng YR; Fontana R
Antimicrob Agents Chemother; 1985 May; 27(5):828-31. PubMed ID: 3848293
[TBL] [Abstract][Full Text] [Related]
13. Beta-lactam-specific resistant mutants of Staphylococcus aureus.
Tonin E; Tomasz A
Antimicrob Agents Chemother; 1986 Oct; 30(4):577-83. PubMed ID: 3539012
[TBL] [Abstract][Full Text] [Related]
14. Binding of beta-lactam antibiotics to penicillin-binding proteins in methicillin-resistant Staphylococcus aureus.
Chambers HF; Sachdeva M
J Infect Dis; 1990 Jun; 161(6):1170-6. PubMed ID: 2345297
[TBL] [Abstract][Full Text] [Related]
15. Production of low-affinity penicillin-binding protein by low- and high-resistance groups of methicillin-resistant Staphylococcus aureus.
Murakami K; Nomura K; Doi M; Yoshida T
Antimicrob Agents Chemother; 1987 Sep; 31(9):1307-11. PubMed ID: 3499861
[TBL] [Abstract][Full Text] [Related]
16. Low-affinity penicillin-binding protein associated with beta-lactam resistance in Staphylococcus aureus.
Hartman BJ; Tomasz A
J Bacteriol; 1984 May; 158(2):513-6. PubMed ID: 6563036
[TBL] [Abstract][Full Text] [Related]
17. RWJ-54428 (MC-02,479), a new cephalosporin with high affinity for penicillin-binding proteins, including PBP 2a, and stability to staphylococcal beta-lactamases.
Malouin F; Blais J; Chamberland S; Hoang M; Park C; Chan C; Mathias K; Hakem S; Dupree K; Liu E; Nguyen T; Dudley MN
Antimicrob Agents Chemother; 2003 Feb; 47(2):658-64. PubMed ID: 12543674
[TBL] [Abstract][Full Text] [Related]
18. Increased amounts of a novel penicillin-binding protein in a strain of methicillin-resistant Staphylococcus aureus exposed to nafcillin.
Chambers HF; Hartman BJ; Tomasz A
J Clin Invest; 1985 Jul; 76(1):325-31. PubMed ID: 4019783
[TBL] [Abstract][Full Text] [Related]
19. Affinities of BO-2727 for bacterial penicillin-binding proteins and morphological change of gram-negative rods.
Hashizume T; Nakamura K; Nakagawa S
J Antibiot (Tokyo); 1997 Feb; 50(2):139-42. PubMed ID: 9099223
[TBL] [Abstract][Full Text] [Related]
20. Molecular correlation between in vitro and in vivo activity of beta-lactam and beta-lactamase inhibitor combinations against methicillin-resistant Staphylococcus aureus.
Fasola EL; Fasching CE; Peterson LR
J Lab Clin Med; 1995 Feb; 125(2):200-11. PubMed ID: 7844469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
